Bimekizumab Efficacy by Prior Biologic Treatment in Patients with Moderate to Severe Hidradenitis Suppurativa: 48-Week Pooled Data from the Randomized, Double-Blind, Placebo-Controlled, Multicenter BE HEARD I and II Phase 3 Trials. J of Skin [Internet]. 2024 Jan. 16 [cited 2026 May 1];8(1):s349. Available from: https://skin.dermsquared.com/skin/article/view/2449